Prevalence and cost of subsequent fractures among U.S. patients with an incident fracture

Journal of Managed Care and Specialty Pharmacy

Volumn 23, Issue 4, 2017, Pages 461-471

  Weaver, Jessica ^a   Sajjan, Shiva ^a   Michael Lewiecki, E ^b   Harris, Steven T ^c   Marvos, Panagiotis ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NEW MEXICO CLINICAL RESEARCH AND OSTEOPOROSIS CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CYTOPROTECTIVE AGENT; DENOSUMAB; ESTROGEN; GLUCOCORTICOID; HISTAMINE H2 RECEPTOR ANTAGONIST; IBANDRONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PARATHYROID HORMONE[1-34]; PROTON PUMP INHIBITOR; RALOXIFENE; RISEDRONIC ACID; ZOLEDRONIC ACID;

ADMINISTRATIVE CLAIMS (HEALTH CARE); ADULT; AGED; ARTICLE; CHARLSON COMORBIDITY INDEX; CURRENT PROCEDURAL TERMINOLOGY; DATA BASE; EMERGENCY WARD; FEMALE; FRAGILITY FRACTURE; HEALTH CARE COST; HEALTH CARE PLANNING; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; ICD-9-CM; INCIDENT FRACTURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MCNEMAR TEST; MEDICARE; MIDDLE AGED; OUTPATIENT CARE; PREVALENCE; PROPENSITY SCORE; RETROSPECTIVE STUDY; SUBSEQUENT FRACTURE; UNITED STATES; VERY ELDERLY; DRUG COST; ECONOMICS; FACTUAL DATABASE; FRACTURES, BONE; INSURANCE; RECURRENT DISEASE; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA;

AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; DRUG COSTS; FEMALE; FRACTURES, BONE; HEALTH CARE COSTS; HUMANS; INSURANCE CLAIM REVIEW; MALE; MEDICARE; MEDICARE PART C; MIDDLE AGED; PREVALENCE; PROPENSITY SCORE; RECURRENCE; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 85016287067     PISSN: 23760540     EISSN: 23761032     Source Type: Journal    
DOI: 10.18553/jmcp.2017.23.4.461     Document Type: Article

References (17)

1. Wright NC, Looker AC, Saag KG, et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res. 2014;29(11):2520-26.
2. Cosman F, de Beur SJ, LeBoffMS, et al. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359-81.
3. Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int. 2009;20(10):1633-50.
4. Bliuc D, Nguyen ND, Milch VE, et al. Mortality risk associated with lowtrauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009;301(5):513-21.
5. Nazrun AS, Tzar MN, Mokhtar SA, Mohamed IN. A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality. Ther Clin Risk Manag. 2014;10:937-48.
6. Kanis JA, Johnell O, De Laet C, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35(2):375-82.
7. Bliuc D, Alarkawi D, Nguyen TV, Eisman JA, Center JR. Risk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density: the Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res. 2015;30(4):637-46.
8. Ahmed LA, Center JR, Bjornerem A, et al. Progressively increasing fracture risk with advancing age after initial incident fragility fracture: the Tromso study. J Bone Miner Res. 2013;28(10):2214-21.
9. Lyles KW, Schenck AP, Colon-Emeric CS. Hip and other osteoporotic fractures increase the risk of subsequent fractures in nursing home residents. Osteoporos Int. 2008;19(8):1225-33.
10. Song X, Shi N, Badamgarav E, et al. Cost burden of second fracture in the U.S. health system. Bone. 2011;48(4):828-36.
11. Pike CT, Birnbaum HG, Schiller M, et al. Prevalence and costs of osteoporotic patients with subsequent non-vertebral fractures in the U.S. Osteoporos Int. 2011;22(10):2611-21.
12. Curtis JR, Arora T, Matthews RS, et al. Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death. J Am Med Dir Assoc. 2010;11(8):584-91.
13. Budhia S, Mikyas Y, Tang M, Badamgarav E. Osteoporotic fractures: a systematic review of U.S. healthcare costs and resource utilization. Pharmacoeconomics. 2012;30(2):147-70.
14. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-19.
15. Orsini LS, Rousculp MD, Long SR, Wang S. Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures. Osteoporos Int. 2005;16(4):359-71.
16. U.S. Department of Labor. Databases, tables & calculators by subject. Consumer Price Index-all urban consumers. Available at: https://www.bls.gov/data/. Accessed June 15, 2016.
17. Center JR, Bliuc D, Nguyen TV, Eisman JA. Risk of subsequent fracture after low-trauma fracture in men and women. JAMA. 2007;297(4):387-94.